Encompass Healthcare and Wound Medicine

IV and Infusion Therapies We Administer

IV and Infusion Therapies Available at Encompass Healthcare

The Encompass HealthCare infusion center is a convenient, comfortable and friendly place to receive your intravenous medications. It is staffed by caring doctors and technicians who treat you like family and are dedicated to providing you with the highest level of professional health care possible.  We serve all cities in Oakland County, Wayne County, Livingston County, and Washtenaw County, including West Bloomfield, Bloomfield Hills, Birmingham, Troy, Farmington/Farmington Hills, Southfield/Berkley, Novi, Northville, Brighton, Commerce Township, Walled Lake, and the greater Metro Detroit area.

Some of the IV and Infusion medicines available at Encompass HealthCare include:

  • Antibiotics
  • Remicade
  • Rituxan
  • Orencia
  • Boniva
  • Zometa
  • Prolastin, Aralast
  • Intavenous immunoglobulin
  • Aranesp
  • Neupogen, Nuelasta
  • Growth hormone
  • Solumedrol
  • Toradol
  • Zofran
  • Reclast

I.V. Antibiotics available include:

  • Rocephin
  • Vancomycin
  • Invanz
  • Zosyn
  • Septra
  • Cubicin
  • Zyvox
  • Cleocin
  • Gentamycin
  • Avelox
  • Levoquin
  • Azactam
  • Tygacil
  • Zythromax
  • Tobramycin
  • Cefepim
  • Cancidas
  • Amikicin
  • Avycav
  • Ceftazidime
  • Colistin
  • Vitamin B12 Injections
  • Decadron
  • Benadryl
  • Doribax
  • Enoxaprin
  • Lasix
  • Ferrlecit (Iron Supplement)
  • Venofer
  • Toradol
  • Lidocaine
  • Meropenem
  • Mycamine
  • Souldemrol
  • Teflaro
  • Unasyn
  • Dalvance
  • Zebaxa
  • Vibativ
  • Orbactiv
  • Mincocin

REMICADE                                                                                                                                

Approved uses:  psoriasis, psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis

IV and Infusion therapies are based on weight and are administered every 4-8 weeks after induction. Intravenous infusion time is approximately three hours. Infusions can be scheduled seven days a week around the patient’s schedule.

RITUXAN

Approved uses: rheumatoid arthritis, pyroderma gangrenosum

Infusion Therapy:  1000 mg per IV infusion separated by two weeks. This medication is currently given with methotrexate.

ORENCIA

Approved uses:  rheumatoid arthritis

Infusion therapies are based on patient body weight. IV infusions lasts only 30 minutes are is administered at two- and four weeks after the first infusion; and then every four weeks thereafter.

BONIVA, Reclast, and Zometa

Approved uses: osteoporosis in post-menopausal women

Infusion Therapy:  3mg per IV injection over 15-30 seconds every 3 months. This drug must be administered by a health professional.

ZOMETA

Approved uses:  hypercalcemia of malignancy, multiple myeloma and bone metastases of solid tumors.

Infusion therapy: 4mg in 100cc sterile .9 sodium chloride over no less than 15minutes.  Treatment frequency is based on diagnosis. This drug is best administered by a health professional.

PROLASTIN or ARALAST

Approved uses:  emphysema due to congenital alpha1-antitrypsin deficiency.  This disease usually presents in the third and fourth decades of life.

Infusion therapy:  60 mg/kg of body weight in sterile water over 30 minutes weekly.  Treatment is indefinite.  Product must be properly stored and maintained to prevent diminished activity.  Admixing must be done according to strict guidelines by professionals with available sterile hoods like those at Encompass HealthCare.

INTAVENOUS IMMUNOGLOBULIN

Approved uses: immunodeficiency, immune thrombocytopenic purport (ITP) and chronic demyelinating peripheral neuropathy.

Infusion therapy is based on weight and diagnosis.  Typically, infusions last for two to four hours, once per month.

ARANESP

Approved uses:  anemia (abnormally low hemoglobin) resulting from chemotherapy, chronic renal insufficiency, or HIV.

Infusion therapy:  subcutaneous or short IV infusion, 15-30 minutes, given weekly or once every three weeks until target hemoglobin is achieved. Shorter-acting Epogen is available for more frequent and more acute indications.  Dose varies based on patient weight and specific indication listed in the approved uses above. Should be administered under the supervision of a healthcare professional such as at Encompass HealthCare.

NEULASTA

Approved uses: to decrease the incidence of infection due to significantly depleted WBC (white blood cell) counts in patients undergoing chemotherapy.  Shorter acting Neupogen is also available for transiently low WBC counts due to chemotherapy.

Infusion therapy:  subcutaneous or short IV infusion, 15-30 minutes, administered once per chemotherapy cycle.  Neupogen is used for more frequent administration in temporary conditions and dose is based on patient weight with daily injections/infusions until target WBC count is achieved.

GROWTH HORMONE

Approved uses:  adult growth hormone deficiency, malnutrition from AIDS, idiopathic short stature

Infusion therapy: subcutaneous injection.  Self-administration is optimal.

SOLUMEDROL

Approved uses: multiple chronic inflammatory disorders which have acute breakthroughs or temporary relapses.  Examples include rheumatoid arthritis, Lupus and multiple sclerosis.  Additionally, the drug is used for asthma, sinusitis and allergic reactions.

TORDOL

Approved uses: acute pain syndromes, migraine

Infusion: short IV infusion over 30-60 seconds.

If you like this page, please share it! 

Leave a Reply

Note: Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.

Encompass HealthCare
Have questions? Call us!248-624-9800